Synthetic Biologics, Inc.
INTESTINAL ALKALINE PHOSPHATASE FORMULATIONS

Last updated:

Abstract:

The present invention provides for a formulation comprising an active alkaline phosphatase (AP)-based agent and an enteric agent, wherein the formulation is suitable for releasing a substantial amount of the active AP-based agent in the intestines.

Status:
Application
Type:

Utility

Filling date:

20 Mar 2019

Issue date:

4 Feb 2021